reports
- Jonathan Moreland
Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Ru...
Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) SOUTH SAN FRANCISCO, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), today announced that on January 21, 2025, it granted stock options to purchase an aggregate of 275,000 shares of common stock upon vesting to Delphine Imbert, Ph.D., the Company’s newly appointed Chief Technical Officer, as a material inducement to her employment. The stock options that were granted are subject to an exercise price of $11.07 per share, which is equal to the closing price of the Company...
Pliant Therapeutics Appoints Delphine Imbert, Ph.D. as Chief Technical...
Pliant Therapeutics Appoints Delphine Imbert, Ph.D. as Chief Technical Officer Dr. Imbert brings 25 years of strategic clinical to commercial-stage manufacturing and drug development experience SOUTH SAN FRANCISCO, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, today announced the appointment of Delphine Imbert, Ph.D. as Chief Technical Officer. Dr. Imbert brings 25 years of product development, process optimizat...
- Jonathan Moreland
OMEX ODYSSEY MARINE EXPLORATION INC.
NEOG NEOGEN CORPORATION
LNDC LANDEC CORP.
CDXS CODEXIS
ASA ASA
NEWT NEWTEK BUSINESS SERVICES INC.
ADC AGREE REALTY CORPORATION
FBK FB FINANCIAL CORPORATION
NQP NUVEEN PENNSYLVANIA INVESTMENT QUALITY MUNICIPAL FUND INC.
LW LAMB WESTON HOLDINGS INC.
ANAB ANAPTYSBIO INC.
DMLP DORCHESTER MINERALS L.P.
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
COGT COGINT
ZIVO INC.
ETST ZIVO BIOSCIENCE
LOVE INC.
FUND EARTH SCIENCE TECH
ANIX LOVESAC
LBSRD ROYCE FOCUS TRUST
ETON INC.
GRX ANIXA BIOSCIENCES
MCFT LIBERTY STAR URANIUM & METALS
PGNY ETON PHARMACEUTICALS
PNTG THE GABELLI HEALTHCARE & WELLNESSRX TRUST
DCTH MASTERCRAFT BOAT HOLDINGS
ENX PROGYNY
PRLD PENNANT GROUP
NOTV DELCATH SYSTEMS
NVCT EATON VANCE NEW YORK MUNICIPAL BOND FUND
ANEB PRELUDE THERAPEUTICS
BHVN INOTIV
ACXP INC.
BUKS NUVECTIS PHARMA INC
GLSI ANEBULO PHARMACEUTICALS INC
MEGI BIOHAVEN LTD
CVI ACURX PHARMACEUTICALS INC
SRFM BUTLER NATIONAL CORP
OCX GREENWICH LIFESCIENCES INC
AVDL MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
TXO CVR ENERGY
MRKR INC.
TTGT SURF AIR MOBILITY INC.
DTIL ONCOCYTE CORPORATION
AMST AVADEL PHARMACEUTICALS PUBLIC LIMITED COMPANY
WHLM MORNINGSTAR PARTNERS
IBIO L.P.
SDHY MARKER THERAPEUTICS INC
TECHTARGET INC.
PRECISION BIOSCIENCES INC.
AMESITE INC.
WILHELMINA INTERNATIONAL INC
IBIO INC.
PGIM SHORT DURATION HIGH YIELD OPPORTUNITIES FUND
- Jonathan Moreland
LW LAMB WESTON HOLDINGS INC.
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
DBI DESIGNER BRANDS INC. CLASS A
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
BUKS BUTLER NATIONAL CORP
AVDL AVADEL PHARMACEUTICALS PUBLIC LIMITED COMPANY
CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed ...
CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights Offering Oversubscribed Rights Offering Generated $6.25 Million in Aggregate Gross Proceeds Offering Proceeds Satisfies Debt Covenant, Unlocking $5.0 Million in Restricted Cash Currently on the Balance Sheet PRINCETON, N.J., Jan. 13, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announced today that the Company closed the subscription period of its previously announced rights offering (t...
- Jonathan Moreland
OXY OCCIDENTAL PETROLEUM CORPORATION
VRSN VERISIGN INC.
OMEX ODYSSEY MARINE EXPLORATION INC.
LNDC LANDEC CORP.
FPI FARMLAND PARTNERS REIT
DEA EASTERLY GOVERNMENT PROPERTIES INC
CDXS CODEXIS
ASA ASA
NEWT NEWTEK BUSINESS SERVICES INC.
ADC AGREE REALTY CORPORATION
CULP CULP INC.
FBK FB FINANCIAL CORPORATION
NQP NUVEEN PENNSYLVANIA INVESTMENT QUALITY MUNICIPAL FUND INC.
LW LAMB WESTON HOLDINGS INC.
ANAB ANAPTYSBIO INC.
DMLP DORCHESTER MINERALS L.P.
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
ZIVO ZIVO BIOSCIENCE
LOVE INC.
FUND LOVESAC
ETON ROYCE FOCUS TRUST
MCFT INC.
PGNY ETON PHARMACEUTICALS
DCTH MASTERCRAFT BOAT HOLDINGS
ENX PROGYNY
REYN DELCATH SYSTEMS
PRLD EATON VANCE NEW YORK MUNICIPAL BOND FUND
NOTV REYNOLDS CONSUMER PRODUCTS INC.
PFX PRELUDE THERAPEUTICS
XLO INOTIV
NVCT INC.
ANEB PHENIXFIN CORP
BHVN XILIO THERAPEUTICS INC
ACXP NUVECTIS PHARMA INC
BUKS ANEBULO PHARMACEUTICALS INC
ECBK BIOHAVEN LTD
GLSI ACURX PHARMACEUTICALS INC
MEGI BUTLER NATIONAL CORP
SCWO ECB BANCORP INC.
CVI GREENWICH LIFESCIENCES INC
SRFM MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
OCX 374WATER INC
SIRI CVR ENERGY
TXO INC.
MRKR SURF AIR MOBILITY INC.
TTGT ONCOCYTE CORPORATION
DTIL SIRIUS XM HLDGS INC NEW
AMST MORNINGSTAR PARTNERS
WHLM L.P.
MARKER THERAPEUTICS INC
TECHTARGET INC.
PRECISION BIOSCIENCES INC.
AMESITE INC.
WILHELMINA INTERNATIONAL INC
CytoSorbents Expands Global Footprint with Opening of New Regional Sal...
CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai PRINCETON, N.J., Jan. 06, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced the opening of a new regional sales subsidiary in Dubai, United Arab Emirates (UAE). The new subsidiary provides a gateway into the Middle East and Africa - regions with increasing demand for advanced medical technologies and high-quality therapies in critical care and cardiac surgery. ...
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Yea...
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue Fourth quarter product revenue growth estimated at 22% to 25% year-over-year Fourth quarter gross margin estimated to improve to approximately 70% Management will host in-person investor meetings in San Francisco during J.P. Morgan Healthcare Conference week PRINCETON, N.J., Jan. 03, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, toda...
Pliant Therapeutics to Participate in the 43rd Annual J.P. Morgan Heal...
Pliant Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference SOUTH SAN FRANCISCO, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that Bernard Coulie, M.D., Ph.D., President and Chief Executive Officer, is scheduled to present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025 at 1:30 p.m. Pacific Time at the Westin St. Francis Hotel in San Francisco. Interested parties may access the live webcast of this presentation by visiting the Investors & Media section of Pliant’s website a...
CytoSorbents Rights Offering Begins
CytoSorbents Rights Offering Begins To Participate, Eligible Stockholders Should Consult Their Broker or Financial Advisor in Advance of the Rights Offering Expiration on January 10, 2025 PRINCETON, N.J., Dec. 23, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: CTSO) announces the commencement of its Rights Offering, previously detailed in our . Stockholders and certain Warrantholders of record on December 16, 2024 are now being distributed a dividend of one non-transferable Subscription Right Warrant (“Subscription Right”) for each share of common stock owned on the record date. Each Subscrip...
- Jonathan Moreland
MTDR MATADOR RESOURCES COMPANY
DLY LYONDELLBASELL INDUSTRIES NV
GLP GLOBAL PARTNERS LP
FISI FINANCIAL INSTITUTIONS INC.
FFIC FLUSHING FINANCIAL CORP.
NSC NORFOLK SOUTHERN CORPORATION
SENS SENSEONICS HOLDINGS
TDW TIDEWATER INC
DOW DOW INC.
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
PHAT PHATHOM PHARMACEUTICALS
CURI CURIOSITYSTREAM INC (A)
MASS 908 DEVICES
CTGO CONTANGO ORE INC.
RMBL RUMBLEON INC
NVCT NUVECTIS PHARMA INC
HR HEALTHCARE TRUST OF AMERICA INC.
BIGZ BLACKROCK INNOVATION AND GROWTH TST
DINO HF SINCLAIR CORP
BHRB BURKE HERBERT FINANCIAL SERVICES CORP
AVDL AVADEL PHARMACEUTICALS PUBLIC LIMITED COMPANY
MIO PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
SPGC SPARTA SURGICAL CORP
- Jonathan Moreland
TTSH TILE SHOP HOLDINGS INC.
PLAY DAVE & BUSTER'S ENTERTAINMENT INC.
MYE MYERS INDUSTRIES INC.
MTDR MATADOR RESOURCES COMPANY
LTRX LANTRONIX INC.
HRZN HORIZON TECHNOLOGY FINANCE CORP.
FCN FTI CONSULTING INC.
CVGI COMMERCIAL VEHICLE GROUP INC.
BAH BOOZ ALLEN HAMILTON HOLDING CORPORATION CLASS A
MEDP MEDPACE HOLDINGS INC.
AUP AURINIA PHARMACEUTICALS INC.
CULP CULP INC.
PETS PETMED EXPRESS INC.
SCVL SHOE CARNIVAL INC.
TREE LENDINGTREE INC.
PMD PSYCHEMEDICS CORP.
DMLP DORCHESTER MINERALS L.P.
LILA LIBERTY LATIN AMERICA A
HHS HARTE-HANKS INC.
ETST EARTH SCIENCE TECH
TCPC BLACKROCK TCP CAPITAL CORP.
DBI DESIGNER BRANDS INC. CLASS A
ORGO ORGANOGENESIS HOLDINGS (A)
ETNB 89BIO
PCB PACIFIC CITY FINANCIAL CORP
RZLT REZOLUTE
RVMD INC.
SSSS REVOLUTION MEDICINES
FTHM SUTTER ROCK CAPITAL CORP.
GNSS FATHOM HOLDINGS
CTGO GENASYS INC
AGL CONTANGO ORE INC.
NOTV AGILON HEALTH
AUID INC.
TRIN INOTIV
TCBX INC.
IBRX IPSIDY INC.
BIGZ TRINITY CAPITAL INC
MODD THIRD COAST BANCSHARES INC
GRNT IMMUNITYBIO INC
UAMY BLACKROCK INNOVATION AND GROWTH TST
TKO MODULAR MEDICAL INC
SRBK GRANITE RIDGE RESOURCES INC
NCDL U S ANTIMONY CORP
SPRU TKO GROUP HOLDINGS
AVDL INC.
CATX SR BANCORP INC
MRAI NUVEEN CHURCHILL DIRECT LENDING CORP
GWAV SPRUCE POWER HOLDING CORP
AVADEL PHARMACEUTICALS PUBLIC LIMITED COMPANY
PERSPECTIVE THERAPEUTICS
INC.
MARPAI
INC.
GREENWAVE TECHNOLOGY SOLUTIONS INC
- Jonathan Moreland
PLAY DAVE & BUSTER'S ENTERTAINMENT INC.
CULP CULP INC.
NSC NORFOLK SOUTHERN CORPORATION
PMD PSYCHEMEDICS CORP.
DMLP DORCHESTER MINERALS L.P.
BBDC BARINGS BDC INC.
DBI DESIGNER BRANDS INC. CLASS A
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
RZLT REZOLUTE
CTGO INC.
NOTV CONTANGO ORE INC.
TRIN INOTIV
IBRX INC.
GRNT TRINITY CAPITAL INC
AVDL IMMUNITYBIO INC
MIO GRANITE RIDGE RESOURCES INC
AVADEL PHARMACEUTICALS PUBLIC LIMITED COMPANY
PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
CytoSorbents to Host Investor Meetings in San Francisco During J.P. Mo...
CytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference Week PRINCETON, N.J., Dec. 12, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announced today that management will host in-person investors meetings in San Francisco alongside the 43rd Annual J.P. Morgan Healthcare Conference being held January 13-15, 2025, in San Francisco, CA. is coordinating meetings on the Company’s behalf. To schedule a meeting with Dr. Ph...
- Jonathan Moreland
MYE MYERS INDUSTRIES INC.
MTDR MATADOR RESOURCES COMPANY
ENTA ENANTA PHARMACEUTICALS INC.
BAH BOOZ ALLEN HAMILTON HOLDING CORPORATION CLASS A
MEDP MEDPACE HOLDINGS INC.
PETS PETMED EXPRESS INC.
ETNB 89BIO
ENX EATON VANCE NEW YORK MUNICIPAL BOND FUND
NOTV INOTIV
AHNR INC.
AUID ATHENA SILVER CORP
ANTX IPSIDY INC.
AVDL AN2 THERAPEUTICS INC
AVADEL PHARMACEUTICALS PUBLIC LIMITED COMPANY
CytoSorbents Announces Rights Offering
CytoSorbents Announces Rights Offering Investors Must Hold or Buy CTSO Common Stock by Close of Nasdaq Trading on Friday, December 13, 2024 to Participate PRINCETON, N.J., Dec. 09, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced the details of its anticipated Rights Offering. Investors who hold or have bought CTSO stock at the close of Nasdaq trading on Friday, December 13, 2024 will be deemed stockholders of record on December 16, 2024 and...
CytoSorbents to Participate at the Piper Sandler 36th Annual Healthcar...
CytoSorbents to Participate at the Piper Sandler 36th Annual Healthcare Conference PRINCETON, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announced today that management will participate at the Piper Sandler 36th Annual Healthcare Conference being held December 3-5, 2024, in New York, NY. Dr. Phillip Chan, Chief Executive Officer, and Peter J. Mariani, Chief Financial Officer, will participate in one-on-one investor meetings on Wednesday, Dece...
Pliant Therapeutics to Participate in Upcoming Investor Events
Pliant Therapeutics to Participate in Upcoming Investor Events SOUTH SAN FRANCISCO, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, today announced participation in the following December investor events. Evercore 7th Annual HealthCONx Conference Members of Pliant’s senior management will meet with investors on Tuesday, December 3, 2024.Citi 2024 Global Healthcare Conference Members of Pliant’s senior manageme...
Pliant Therapeutics Presents Data from its Bexotegrast Program at The ...
Pliant Therapeutics Presents Data from its Bexotegrast Program at The Liver Meeting® 2024 INTEGRIS-PSC featured in an oral late breaker presentation SOUTH SAN FRANCISCO, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, today announced the presentation of clinical data at The Liver Meeting® 2024 of the American Association for the Study of Liver Diseases (AASLD) being held in San Diego, California. In an oral lat...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.